Please login to the form below
Takecab
This page shows the latest Takecab news and features for those working in and with pharma, biotech and healthcare.
Biologics set to revolutionise the gastrointestinal market
Also contributing to the predicted market growth are recent product approvals such as Takeda's Takecab (vonoprazan) for gastroesophageal reflux disease, and Entvio (vedolizumab) for IBD.
Latest news
-
Rare disease therapies head the ‘class of 2015’
Baxalta. USA. vonoprazan fumarate. Takecab. acid-related diseases. potassium-competitive acid blocker. Takeda/Otsuka.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager (PR)
-
Great Benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director, Medical Education
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager
-
£Competitive Salary
-
Senior Medical Writer
-
Salary TBC
-
Account Director
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- China backs use of Roche’s Actemra for coronavirus
- Novartis forms coronavirus alliance with life sciences companies
- FDA approves Roche’s Actemra COVID-19 trial
- UK biotech Synairgen to begin COVID-19 trial of lead candidate
- COVID-19: Novel coronavirus remains stable on surfaces for hours
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Behaviour change – is there something missing?
- Lundbeck drops Parkinson’s drug acquired in €905m deal
- AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq
- The global antibiotic crisis: a 2020 perspective
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- The global antibiotic crisis: a 2020 perspective
- A report from the CDC says the ‘approaching’ post-antibiotic era is already here...
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
Quick links
Infographics
